vs
Side-by-side financial comparison of Cherry Hill Mortgage Investment Corp (CHMI) and TriSalus Life Sciences, Inc. (TLSI). Click either name above to swap in a different company.
TriSalus Life Sciences, Inc. is the larger business by last-quarter revenue ($13.2M vs $11.8M, roughly 1.1× Cherry Hill Mortgage Investment Corp). On growth, TriSalus Life Sciences, Inc. posted the faster year-over-year revenue change (59.8% vs -37.2%). Over the past eight quarters, TriSalus Life Sciences, Inc.'s revenue compounded faster (43.0% CAGR vs -15.2%).
Cherry Hill Mortgage Investment Corp is a U.S.-headquartered real estate finance firm focused on acquiring, investing in and managing residential mortgage-related assets. Its core holdings include agency mortgage-backed securities, residential loans and mortgage servicing rights, operating primarily in the U.S. domestic housing finance market.
TriSalus Life Sciences, Inc. is a clinical-stage biotechnology company focused on advancing immuno-oncology and interventional oncology solutions. It develops proprietary targeted drug delivery technologies designed to improve treatment efficacy for patients with liver, pancreatic and other hard-to-treat solid tumors, primarily operating in North American markets via partnerships with clinical care and research institutions.
CHMI vs TLSI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $11.8M | $13.2M |
| Net Profit | — | $-9.8M |
| Gross Margin | 78.9% | 86.7% |
| Operating Margin | 72.1% | -24.8% |
| Net Margin | — | -73.9% |
| Revenue YoY | -37.2% | 59.8% |
| Net Profit YoY | — | 3.5% |
| EPS (diluted) | $0.18 | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $11.8M | $13.2M | ||
| Q3 25 | $8.6M | $11.6M | ||
| Q2 25 | $6.0M | $11.2M | ||
| Q1 25 | $-3.0M | $9.2M | ||
| Q4 24 | $18.7M | $8.3M | ||
| Q3 24 | $-7.1M | $7.3M | ||
| Q2 24 | $6.6M | $7.4M | ||
| Q1 24 | $16.3M | $6.5M |
| Q4 25 | — | $-9.8M | ||
| Q3 25 | $4.5M | $-10.8M | ||
| Q2 25 | $1.6M | $-8.3M | ||
| Q1 25 | $-7.0M | $-10.4M | ||
| Q4 24 | — | $-10.1M | ||
| Q3 24 | $-12.4M | $-2.4M | ||
| Q2 24 | $784.0K | $-4.3M | ||
| Q1 24 | $12.1M | $-13.2M |
| Q4 25 | 78.9% | 86.7% | ||
| Q3 25 | 73.2% | 83.5% | ||
| Q2 25 | 67.7% | 83.9% | ||
| Q1 25 | 183.4% | 83.7% | ||
| Q4 24 | 83.3% | 85.3% | ||
| Q3 24 | 145.3% | 86.3% | ||
| Q2 24 | 47.5% | 87.6% | ||
| Q1 24 | 83.9% | 85.0% |
| Q4 25 | 72.1% | -24.8% | ||
| Q3 25 | 56.0% | -77.9% | ||
| Q2 25 | 44.4% | -65.4% | ||
| Q1 25 | 223.6% | -79.9% | ||
| Q4 24 | 76.2% | -91.8% | ||
| Q3 24 | 171.8% | -118.9% | ||
| Q2 24 | 22.0% | -111.0% | ||
| Q1 24 | 78.0% | -180.8% |
| Q4 25 | — | -73.9% | ||
| Q3 25 | 52.7% | -93.5% | ||
| Q2 25 | 25.9% | -73.9% | ||
| Q1 25 | 229.2% | -113.2% | ||
| Q4 24 | — | -122.4% | ||
| Q3 24 | 175.8% | -32.6% | ||
| Q2 24 | 11.9% | -58.8% | ||
| Q1 24 | 73.7% | -204.5% |
| Q4 25 | $0.18 | $-0.22 | ||
| Q3 25 | $0.05 | $-0.96 | ||
| Q2 25 | $-0.03 | $-0.27 | ||
| Q1 25 | $-0.29 | $-0.39 | ||
| Q4 24 | $0.30 | $-0.38 | ||
| Q3 24 | $-0.49 | $-0.12 | ||
| Q2 24 | $-0.06 | $-0.21 | ||
| Q1 24 | $0.32 | $-0.60 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $54.9M | $20.4M |
| Total DebtLower is stronger | $146.3M | — |
| Stockholders' EquityBook value | $236.0M | $-33.9M |
| Total Assets | $1.5B | $35.3M |
| Debt / EquityLower = less leverage | 0.62× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $54.9M | $20.4M | ||
| Q3 25 | $55.4M | $22.7M | ||
| Q2 25 | $58.0M | $26.5M | ||
| Q1 25 | $47.3M | $13.0M | ||
| Q4 24 | $46.3M | $8.5M | ||
| Q3 24 | $50.2M | $11.3M | ||
| Q2 24 | $52.4M | $16.5M | ||
| Q1 24 | $47.5M | $4.0M |
| Q4 25 | $146.3M | — | ||
| Q3 25 | $148.0M | — | ||
| Q2 25 | $150.1M | — | ||
| Q1 25 | $150.1M | — | ||
| Q4 24 | $152.1M | — | ||
| Q3 24 | $151.8M | — | ||
| Q2 24 | $160.5M | — | ||
| Q1 24 | $167.5M | — |
| Q4 25 | $236.0M | $-33.9M | ||
| Q3 25 | $233.1M | $-26.7M | ||
| Q2 25 | $229.9M | $-19.4M | ||
| Q1 25 | $226.6M | $-34.4M | ||
| Q4 24 | $230.3M | $-25.9M | ||
| Q3 24 | $236.7M | $-20.4M | ||
| Q2 24 | $234.5M | $-25.3M | ||
| Q1 24 | $247.0M | $-36.0M |
| Q4 25 | $1.5B | $35.3M | ||
| Q3 25 | $1.5B | $36.5M | ||
| Q2 25 | $1.5B | $41.3M | ||
| Q1 25 | $1.4B | $28.6M | ||
| Q4 24 | $1.5B | $24.0M | ||
| Q3 24 | $1.6B | $27.5M | ||
| Q2 24 | $1.4B | $32.4M | ||
| Q1 24 | $1.4B | $17.9M |
| Q4 25 | 0.62× | — | ||
| Q3 25 | 0.63× | — | ||
| Q2 25 | 0.65× | — | ||
| Q1 25 | 0.66× | — | ||
| Q4 24 | 0.66× | — | ||
| Q3 24 | 0.64× | — | ||
| Q2 24 | 0.68× | — | ||
| Q1 24 | 0.68× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $19.1M | $-2.5M |
| Free Cash FlowOCF − Capex | — | $-2.5M |
| FCF MarginFCF / Revenue | — | -19.1% |
| Capex IntensityCapex / Revenue | — | 0.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-19.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $19.1M | $-2.5M | ||
| Q3 25 | $-2.4M | $-3.7M | ||
| Q2 25 | $12.5M | $-7.3M | ||
| Q1 25 | $682.0K | $-4.5M | ||
| Q4 24 | $-4.7M | $-5.7M | ||
| Q3 24 | $4.4M | $-10.8M | ||
| Q2 24 | $4.1M | $-13.4M | ||
| Q1 24 | $-19.1M | $-10.9M |
| Q4 25 | — | $-2.5M | ||
| Q3 25 | — | $-3.9M | ||
| Q2 25 | — | $-7.4M | ||
| Q1 25 | — | $-5.3M | ||
| Q4 24 | — | $-5.8M | ||
| Q3 24 | — | $-11.0M | ||
| Q2 24 | — | $-13.5M | ||
| Q1 24 | — | $-10.9M |
| Q4 25 | — | -19.1% | ||
| Q3 25 | — | -33.9% | ||
| Q2 25 | — | -66.1% | ||
| Q1 25 | — | -57.3% | ||
| Q4 24 | — | -69.7% | ||
| Q3 24 | — | -149.9% | ||
| Q2 24 | — | -183.1% | ||
| Q1 24 | — | -169.3% |
| Q4 25 | — | 0.3% | ||
| Q3 25 | — | 1.9% | ||
| Q2 25 | — | 0.8% | ||
| Q1 25 | — | 8.2% | ||
| Q4 24 | — | 0.6% | ||
| Q3 24 | — | 2.3% | ||
| Q2 24 | — | 0.8% | ||
| Q1 24 | — | 1.0% |
| Q4 25 | — | — | ||
| Q3 25 | -0.53× | — | ||
| Q2 25 | 7.98× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 5.18× | — | ||
| Q1 24 | -1.58× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
